Core Viewpoint - Zealand Pharma A/S will host a conference call on August 14, 2025, to present its second quarter financial results for 2025 [1] Group 1: Conference Call Details - The conference call will take place at 2:00 pm CET (8:00 am ET) [1] - Key executives participating in the call include President and CEO Adam Steensberg, CFO Henriette Wennicke, CMO David Kendall, and CCO Eric Cox [2] - A live audio webcast and slide presentation will be available for participants [3] Group 2: Company Overview - Zealand Pharma A/S is a biotechnology company focused on peptide-based medicines, with over 10 drug candidates in clinical development [4] - The company has successfully brought two drug candidates to market and has three candidates in late-stage development [4] - Zealand Pharma has established development and commercial partnerships with various pharmaceutical companies [4] Group 3: Company Background - Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, and has a presence in the U.S. [5]

Core Points - Zealand Pharma A/S will host a conference call on May 8, 2025, at 2:00 pm CET (8:00 am ET) to present its financial results for the first quarter of 2025 [1] - The call will feature key executives including the President and CEO, CFO, CMO, and CCO, followed by a Q&A session [2] - A live audio webcast and slide presentation will be available for participants, with a recording accessible afterward on the company's investor website [3] Company Overview - Zealand Pharma A/S is a biotechnology company focused on the discovery and development of peptide-based medicines, with over 10 drug candidates in clinical development, including two that have reached the market and three in late-stage development [4] - The company has established development and commercial partnerships with various pharmaceutical companies for its marketed products [4] - Founded in 1998 and headquartered in Copenhagen, Denmark, Zealand Pharma also has a presence in the U.S. [5]